Comment on “Serum ANGPTL4 as a biomarker for hemorrhagic transformation after endovascular therapy in acute ischemic stroke”

Journal of the Formosan Medical Association · Published 2026-06-01 · DOI 10.1016/j.jfma.2026.06.005

Free full text

Authors (1)

Xu Fan

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Fan, X. (2026). Comment on “Serum ANGPTL4 as a biomarker for hemorrhagic transformation after endovascular therapy in acute ischemic stroke”. Journal of the Formosan Medical Association. https://doi.org/10.1016/j.jfma.2026.06.005

Related articles

• Response to the comments on “Evolution of COVID-19 antiviral interventions in Taiwan, 2022–2025: Insights from public health policy” · Journal of the Formosan Medical Association · 2026 · Same journal
• Comment on “Prevalence, risk factors, and management of adult asthma in Taipei, Taiwan: A global asthma network study” · Journal of the Formosan Medical Association · 2026 · Same journal
• Authorship statement · Journal of the Formosan Medical Association · 2026 · Same journal
• Massive loss to follow-up undermines population-based interpretation of H. pylori eradication efficacy in Chiayi county community screening · Journal of the Formosan Medical Association · 2026 · Same journal
• Checklist · Journal of the Formosan Medical Association · 2026 · Same journal
• Highlights · Journal of the Formosan Medical Association · 2026 · Same journal
• Disability is an independent predictor of mortality in patients with spinal cord injury · Journal of the Formosan Medical Association · 2026 · Same journal
• Random skin biopsy for diagnosis of intravascular lymphoma · Journal of the Formosan Medical Association · 2026 · Same journal
• Response to “Comment on ‘Unveiling the characteristics of lobar-predominant cerebral microbleeds in Fabry disease”’ · Journal of the Formosan Medical Association · 2026 · Same journal
• Response to “Comment on 'recent trends of LDL-C control and lipid-lowering therapy in patients with ASCVD in Taiwan: 2015–2020” · Journal of the Formosan Medical Association · 2026 · Same journal